Give Today
Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

In My Community
Research
Text Size controlsNormal font sizeMedium font sizeLarge font size

   

Visit the Alzheimer's Association Research Center - alz.org/research

Participating in Research - Alzheimer's Association Trial Match

If you are interested in participating in research, you can find local and regional research studies that are currently recruiting using the Alzheimer's Association Trial Match program. You can search on-line or simply call 1.800.272.3900.  Click here to learn more.



Local Clinical Trial

Dr. Lawrence Goldstick
Description: Several drug studies of Alzheimer's Disease / Dementia / Age Association Memory Impairment.  Study drugs include LY3202626, Crenezumab and Solanezumab.  Please contact the research coordinator listed below to learn more and discuss your situation. 

Contact:
Kayla Stallworth, CRC
Clinical Research Coordinator
kayla.stallworth@uchealth.com
UC Health Neurology (affiliated with UC but located in Dayton)
1 Elizabeth Place, Suite 210
Dayton, OH  45417
Phone: 937.535.5014
Fax: 937.853.1504


Local Clinical Trial

Research studies at Valley Medical Research, Meenakski Patel, MD, Principal Investigator
Description: Several drug studies for people with mild to moderate cognitive impairment or Alzheimer's.  In addition, one study of agitation and Alzheimer's and another for a brain donation study for those with <6 mos. life expectancy.  For more information, please contact the research coordinator listed below:
All studies require a caregiver or study partner, all studies have a placebo, all studies compensate for time and travel.

Contact:
Cynthia Whittington, RN, MSN
rncynthia@aol.com
Valley Medical Research
Meenakshi Patel, MD (PI)
6611 Clyo Road
Centerville, OH 
937.208.8298 office
937.208.8276 fax



Local Clinical Trial

Early Alzheimer's Disease Clinical Research Study
Description: The EXPEDITION-PRO study will test whether the intravenous investigational drug, solanezumab, slows the worsening of Alzheimer's disease (AD) as compared to placebo in people with early Alzheimer's disease.  About the study The EXPEDITION-PRO Study is a clinical research study involving men and women who have early AD.  It is being conducted worldwide to find out if the study drug is safe and effective in slowing down the progression of the disease.  Approximately 2,450 participants are expected to join this study worldwide. 

Contact:
Grace R. Smither
Tel: 937.224.8200 Ext 125
gsmither@ndidayton.com
Dr. Joel Vandersluis, MD
Neurology Diagnostics, Inc.
240 West Elmwood Dr., Ste 1000
Dayton, OH  45459



 

 


 

Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.